Atherosclerosis
Volume 213, Issue 1 , Pages 191-199 , November 2010

A1166C genetic variation of the angiotensin II type I receptor gene and susceptibility to coronary heart disease: Collaborative of 53 studies with 20,435 cases and 23,674 controls

  • Mingqing Xu

      Affiliations

    • Brigham and Women's Hospital, School of Medicine, Harvard University, Boston, MA 02115, USA
    • School of Public Health, Harvard University, 665 Huntington Avenue, Boston, MA 02115, USA
    • Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, PR China
    • Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, PR China
    • Institute for Nutritional Sciences, Chinese Academy of Sciences, Shanghai 200031, PR China
    • Corresponding Author InformationCorresponding author at: Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, PR China; Brigham and Women's Hospital, School of Medicine, Harvard University, Boston, MA 02115, USA. Tel.: +1 6174322984; fax: +16174322984.
    • ,
  • Pak Sham

      Affiliations

    • HKU Department of Psychiatry and Genome Research Centre, University of Hong Kong, Pokfulam Road, Hong Kong, PR China
    • ,
  • Zheng Ye

      Affiliations

    • Department of Public Health and Primary Care, University of Cambridge, Strangeways Site, Worts Causeway, Cambridge CB1 8RN, UK
    • ,
  • Klaus Lindpaintner

      Affiliations

    • Roche Center for Medical Genomics, F. Hoffmann-La Roche, Ltd., Basel, Switzerland
    • ,
  • Lin He

      Affiliations

    • Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, PR China
    • Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, PR China
    • Institute for Nutritional Sciences, Chinese Academy of Sciences, Shanghai 200031, PR China
    • Corresponding Author InformationCorresponding author at: Institutes of Biomedical Sciences, Fudan University, 138 Yixueyuan Road, Shanghai 200032, PR China; Institute for Nutritional Sciences, Chinese Academy of Sciences, Shanghai 200031, PR China. Tel.: +862162822491; fax: +862162822491.

Received 2 February 2010 ,Revised 19 July 2010 ,Accepted 20 July 2010.

References 

  1. Hsueh WA. Effect of the renin–angiotensin system in the vascular disease of type II diabetes mellitus. Am J Med. 1992;92:13S–19S
  2. Wang JG, Staessen JA. Genetic polymorphism in the renin–angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol. 2000;410:289–302
  3. Harrap SB. Cardiovascular disease and genetics of the renin–angiotensin system. Heart. 1996;76:13–17
  4. Xu MQ, Ye Z, Hu FB, He L. Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease. Circulation. 2007;116:1356–1366
  5. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11–34
  6. Tiret L, Bonnardeaux A, Poirier O, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910–913
  7. Nakauchi Y, Suehiro T, Yamamoto M, et al. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis. 1996;125:161–169
  8. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet. 1997;52:71–76
  9. Poirier O, Georges JL, Ricard S, et al. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde. J Hypertens. 1998;16:1443–1447
  10. Bogaty P, Robitaille NM, Solymoss S, et al. Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina. Am Heart J. 1998;136:884–893
  11. Gardemann A, Nguyen QD, Humme J, et al. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur Heart J. 1998;19:1657–1665
  12. Alvarez R, Reguero JR, Batalla A, et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res. 1998;40:375–379
  13. Rice GI, Foy CA, Grant PJ. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease. Cardiovasc Res. 1999;41:746–753
  14. Karjalainen J, Kujala UM, Stolt A, et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol. 1999;34:494–499
  15. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, et al. The genotype interactions of methylenetetrahydrofolate reductase and renin–angiotensin system genes are associated with myocardial infarction. Atherosclerosis. 1999;145:293–300
  16. Olivieri O, Trabetti E, Grazioli S, et al. Genetic polymorphisms of the renin–angiotensin system and atheromatous renal artery stenosis. Hypertension. 1999;34:1097–1100
  17. Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet. 2000;355:434–442
  18. Canavy I, Henry M, Morange PE, et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost. 2000;83:212–216
  19. Zhong Y, Ha D. The relationship between angiotensin II type 1 receptor gene polymorphism and Chinese essential hypertension. Acta Academiae Medicinae Hubei. 2000;21:124–127
  20. Fatini C, Abbate R, Pepe G, et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J. 2000;21:633–638
  21. Stangl K, Cascorbi I, Stangl V, et al. A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventions. Am Heart J. 2000;140:170–175
  22. Surber R, Sigusch HH, Lehmann MH, et al. Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease. Clin Genet. 2000;58:237–238
  23. Kee F, Morrison C, Poirier O, et al. Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women. Eur J Clin Invest. 2000;30:1076–1082
  24. Batalla A, Alvarez R, Reguero JR, et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem. 2000;46:1910–1915
  25. Steeds RP, Wardle A, Smith PD, et al. Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis. 2001;154:123–128
  26. van Geel PP, Pinto YM, Zwinderman AH, et al. Increased risk for ischaemic events is related to combined RAS polymorphism. Heart. 2001;85:458–462
  27. Petrovic D, Zorc M, Kanic V, Peterlin B. Interaction between gene polymorphisms of renin–angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology. 2001;52:247–252
  28. Olivieri O, Stranieri C, Girelli D, et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens. 2001;19:879–884
  29. Aoki S, Mukae S, Itoh S, et al. Genetic background in patients with acute myocardial infarction. Jpn Heart J. 2001;42:15–28
  30. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, et al. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet. 2001;60:52–57
  31. Deng YL, Yu HZ, Yang Q, Cheng M, Huang DJ. Relation between coronary artery disease and polymorphism of type 1 angiotensin II receptor gene. South China J Cardiovasc Dis. 2001;7:258–260
  32. Liu R, Cheng YC, Bai H, et al. Association between angiotensin II type 1 receptor A1166C polymorphism and coronary heart disease in Chinese. J WCUMS. 2002;33:533–535
  33. Peng J, Peng S, Gong WX. Association between early-onset coronary heart disease and angiotensin II type 1 receptor gene polymorphism. Natl Med J China. 2002;82:471–473
  34. Hooper WC, Dowling NF, Wenger NK, et al. Relationship of venous thromboembolism and myocardial infarction with the renin–angiotensin system in African-Americans. Am J Hematol. 2002;70:1–8
  35. Nakai K, Habano W, Fujita T, et al. Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry. Hum Mutat. 2002;20:133–138
  36. Ermis C, Tsai MY, Hanson NQ, Akar N, Aras O. Angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population. Thromb Haemost. 2002;88:693–694
  37. Hindorff LA, Heckbert SR, Tracy R, et al. Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens. 2002;15:1050–1056
  38. Buraczynska M, Pijanowski Z, Spasiewicz D, et al. Renin–angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol. 2003;58:1–9
  39. Jones A, Dhamrait SS, Payne JR, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension. 2003;42:500–506
  40. Guan LX, Zhang YZ, Wang JX, et al. Association between the type 1 angiotensin II receptor (AT1R) gene A1166C polymorphism and insulin resistance in patients with type 2 diabetes. Chin J Birth Health Hered. 2003;11:30–32
  41. Jin W, Liu Y, Sheng HH, et al. Single nucleotide polymorphisms in promoter of angiotensin II type 1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population. Acta Pharmacol Sin. 2003;24:1083–1088
  42. Zhang RZ, Wang SY, Dai Y, Zhai LH, Xu H. Association between angiotensin II type 1 receptor gene polymorphism and hypertension with coronary artery disease. China J Mod Med. 2004;14:38–40
  43. Ranjith N, Pegoraro RJ, Rom L, Lanning PA, Naidoo DP. Renin–angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians. Cardiovasc J S Afr. 2004;15:22–26
  44. Fan XH, Li L, Qiu CG, Liu RY, Huang ZW. Analysis of the relationship between angiotensin II type 1 receptor gene polymorphism and the severity of coronary artery disease. J Zhengzhou Univ (Med Sci). 2004;39:584–586
  45. Zhu TN, Pan JQ, Shen ZJ, Zhao YQ, Shen T. Gene polymorphisms of renin–angiotensin system and coronary artery thrombosis disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004;12:674–679
  46. Andrikopoulos GK, Richter DJ, Needham EW, et al. The paradoxical association of common polymorphisms of the renin–angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2004;11:477–483
  47. Berdeli A, Sekuri C, Sirri Cam F, et al. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta. 2005;351:87–94
  48. Sekuri C, Cam FS, Ercan E, et al. Renin–angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst. 2005;6:38–42(contact author)
  49. Ozisik K, Misirlioglu M, Ulus TA, et al. Renin–angiotensin system polymorphisms and coronary artery surgery patients. Asian Cardiovasc Thorac Ann. 2005;13:153–156
  50. Zhang KX, Liu TB, Xu QX, Zhu DL, Huang W. Association of angiotensin II receptor type 1 gene single nucleotide polymorphism with Chinese essential hypertension complicated with coronary heart disease. Chin J Cardiol. 2005;33:720–723
  51. Araujo MA, Goulart LR, Cordeiro ER, et al. Genotypic interactions of renin–angiotensin system genes in myocardial infarction. Int J Cardiol. 2005;103:27–32
  52. Jia YP, Ren J, Lu JY, Guo XH. The relationship between coronary heart disease and polymorphism of angiotensiongen and angiotensin II type 1 receptor genes. Chin J Cardiovasc Rev. 2005;3:816–819
  53. Methot J, Hamelin BA, Bogaty P, et al. ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women. Int J Cardiol. 2005;105:308–314
  54. Ding YP. Analysis on angiotensin receptor polymorphism in high-risk population with primary hypertension and coronary heart disease. J Henan Univ Sci Tech (Med Sci). 2006;24:86–88
  55. Jia YP, Guo XH, Lu JY, et al. Relationship between angiotensin II type 1 receptor gene A1166/C polymorphism and coronary heart disease. Chin J Integr Med Cardio-Cerebrovasc Dis. 2006;4:568–570
  56. Lin XF, Xia XM, Ceng LR, Jin LZ, Li J. Relationship between angiotensin system gene polymorphisms and premature coronary artery disease. Clin Med China. 2006;22:971–974
  57. Tsai CT, Hwang JJ, Ritchie MD, et al. Renin–angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis. 2007;195:172–180
  58. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297:1551–1561
  59. Franco E, Palumbo L, Crobu F, et al. Renin–angiotensin–aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet. 2007;8:27
  60. Schelleman H, Klungel OH, Witteman JC, et al. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis. Br J Clin Pharmacol. 2007;64:57–66
  61. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896–1900
  62. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012
  63. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  64. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  65. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693–2708
  66. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101
  67. Duval S, Tweedie R. A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89–98
  68. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006 Sep 16;333:597–600
  69. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  70. Jeffrey DS. Publication Bias: The “File-Drawer Problem” in Scientific Inference. J Sci Exploration. 2000;14:94–106
  71. Shiffman D, Ellis SG, Rowland CM, et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet. 2005;77:596–605
  72. Ozaki K, Tanaka T. Genome-wide association study to identify single-nucleotide polymorphisms conferring risk of myocardial infarction. Methods Mol Med. 2006;128:173–180
  73. Wellcome Trust Case Control Consortium . Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–678
  74. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491
  75. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453
  76. Larson MG, Atwood LD, Benjamin EJ, et al. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet. 2007;8(Suppl. 1):S5
  77. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177–182
  78. Morgan TM, Coffey CS, Krumholz HM. Overestimation of genetic risks owing to small sample sizes in cardiovascular studies. Clin Genet. 2003;64:7–17
  79. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361:865–872
  80. Hirschhorn JN, Lohmueller KE, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45–61
  81. Ionnidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003;361:567–571
  82. Ioannidis JP, Gwinn M, Little J, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006;38:3–5
  83. Seminara D, Khoury MJ, O’Brien TR, et al. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007;18:1–8
  84. Kavvoura FK, Ioannidis JP. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet. 2008;123:1–14
  85. Kavvoura FK, McQueen MB, Khoury MJ, et al. Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease. Am J Epidemiol. 2008;168:855–865
  86. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40:827–834
  87. Bagade S, Allen NC, Tanzi R, Bertram L. The PDGene Database. Alzheimer Research Forum. Available at: http://www.pdgene.org/. Accessed [date of access].
  88. Evangelou E, Maraganore DM, Ioannidis JP. Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS ONE. 2007;2:e196
  89. Baum AE, Hamshere M, Green E, et al. Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry. 2008;13:466–467
  90. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–645
  91. Cooper JD, Smyth DJ, Smiles AM, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet. 2008;40:1399–1401
  92. Houlston RS, Webb E, Broderick P, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008;40:1426–1435
  93. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 2006;15:1995–2002
  94. Takkouche B, Regueira-Méndez C, Etminan M. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst. 2008;100:1439–1447
  95. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet. 2004;363:689–695
  96. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367:651–658
  97. Ntzani EE, Rizos EC, Ioannidis JP. Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol. 2007;165:973–984

PII: S0021-9150(10)00591-5

doi: 10.1016/j.atherosclerosis.2010.07.046

Atherosclerosis
Volume 213, Issue 1 , Pages 191-199 , November 2010

Article Tools

* Image Usage & Resolution